Beasley, Richard http://orcid.org/0000-0003-0337-406X
Harper, James
Bird, Grace
Dunphy, Harriette
Semprini, Alex
Pavord, Ian D.
Papi, Alberto
Weatherall, Mark
Article History
Received: 25 October 2018
Accepted: 27 November 2019
First Online: 28 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: RB has participated in advisory boards for AstraZeneca, GlaxoSmithKline and Novartis; received research grants from AstraZeneca, Cephalon, Fisher & Paykel, Genentech, GlaxoSmithKline, Novartis and Sanofi Aventis, and received payment for lectures or support to attend meetings from AstraZeneca and GlaxoSmithKline. IDP has received speaker’s honoraria for speaking at sponsored meetings from Astra Zeneca, Boehringer Ingelhiem, Aerocrine, Almirall, Novartis, Teva, Chiesi and GSK and payments for organising educational events from AZ and Teva. He has received honoraria for attending advisory panels with Genentech, Regeneron, Astra Zeneca, Boehringer Ingelheim, GSK, Novartis, Teva, Merck, Sanofi, Circassia, Chiesi and Knopp. He has received sponsorship to attend international scientific meetings from Boehringer Ingelheim, GSK, Astra Zeneca, Teva and Chiesi. He has received a grant from Chieisi to support a phase 2 clinical trial in Oxford. AP reports grants, personal fees, non-financial support and other from Chiesi, AstraZeneca, GlaxoSmithKilne, Boehringer Ingelheim, Mundipharma and TEVA, personal fees and non-financial support from Menarini, Novartis and Zambon. JH has received sponsorships to attend an international scientific meeting from GSK. The other authors have no conflict of interest to declare.